International Patent: RECOMBINANT HPV16 E6E7 ADENOVIRUS, VACCINE THEREOF, METHOD FOR PREPARING SAME, AND USE THEREOF

GENEVA, Aug. 31 -- WESTVAC BIOPHARMA CO., LTD. filed a patent application (CN2025/078481) for “RECOMBINANT HPV16 E6E7 ADENOVIRUS, VACCINE THEREOF, METHOD FOR PREPARING SAME, AND USE THEREOF”. With publication no. WO/2026/174523, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 7/01

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....